Evidence map›Paper›PMID 33389601›Full record

ArticleCardiovascular toxicology2021

Effects of Melatonin and Adrenomedullin in Reducing the Cardiotoxic Effects of Doxorubicin in Rats.

Gulcin Durdagi, Deniz Yildiz Pehlivan, Eser Oz Oyar, Selen Akyol Bahceci, Mustafa Ozbek

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Cardiovascular toxicology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Gulcin DurdagiFaculty of Medicine, Department of Physiology, Izmir Katip Celebi University, Izmir, Turkey. durdagigulcin@gmail.com.ORCID 0000-0002-1163-0767
Deniz Yildiz PehlivanFaculty of Medicine, Department of Physiology, Izmir Katip Celebi University, Izmir, Turkey.
Eser Oz OyarFaculty of Medicine, Department of Physiology, Izmir Katip Celebi University, Izmir, Turkey.
Selen Akyol BahceciFaculty of Medicine, Department of Histology and Embryology, Izmir Katip Celebi University, Izmir, Turkey.
Mustafa OzbekFaculty of Medicine, Department of Physiology, Manisa Celal Bayar University, Manisa, Turkey.
Izmir Kâtip Çelebi University · TRManisa Celal Bayar University · TR

Funding

İzmir Katip Çelebi Üniversitesi (TR) 2015- ÖNP-TIPF-0016
6 · The paper itself

Abstract

The main disadvantage of doxorubicin (DOX) is that it has cardiotoxic side effects. Our aim is to evaluate the cardioprotective effects of adrenomedullin (ADM) and to compare these effects with melatonin (MEL), it's cardioprotective effects are well known. Rats were divided into four groups: Control group (0.9% NaCl solution, intravenously), Doxorubicin group (45 mg/kg DOX, intravenously), Doxorubicin + Melatonin group (DOX + MEL, 10 mg/kg melatonin, intraperitoneally), Doxorubicin + Adrenomedullin group (DOX + ADM, 12 µg/kg adrenomedullin, intraperitoneally). A single dose of DOX was injected to the experimental groups on day 5, and a single dose of 0.9% NaCl solution was injected to the control group through the tail vein. The animals were anesthetized and ECG recordings were obtained on day 8. For the purpose of biochemical and histological analysis, cardiac tissue biopsy was obtained after ECG recordings. Compared to the control group, the DOX group had significantly increased duration of QRS complex, PR interval, QT interval and QTc interval. QRS complex, QT interval and QTc interval were prolonged with the administration of DOX and shortened with the administration of ADM. MEL weakened the toxic effects of DOX on the cardiac tissue and it is shown histologically. DOX increased interleukins (IL-1α, IL-6, IL-18), tumor necrosis factor-α (TNF-α), hypoxia-inducible factor 1-alpha (HIF-1α), malondialdehyde (MDA), nitric oxide (NO), creatine kinase myocardial band (CK-MB), and total oxidant status (TOS) levels in cardiac tissue, while reducing total antioxidant status (TAS), superoxide dismutase (SOD) and catalase (CAT) levels. MEL administration decreased the levels of CK-MB, MDA, IL-1α, IL-6, IL-18, NO, and TNF-α, whereas ADM only decreased IL-1α, IL-18, MDA and TNF-α levels. In summary, these results show that DOX has toxic effects on rat cardiac tissue which is documented histologically, electrocardiographically and biochemically. MEL alleviated histological damage and showed improvement on the several biochemical parameters of cardiac tissue. ADM brought several electrocardiographic and biochemical parameters closer to normal values.

Indexed as

Action PotentialsAdrenomedullinAnimalsAnti-Inflammatory AgentsAntioxidantsCardiotoxicityCytokinesDisease Models, AnimalDoxorubicinHeart DiseasesHeart RateHypoxia-Inducible Factor 1, alpha SubunitInflammation MediatorsMaleMelatoninMyocytes, CardiacAdrenomedullinAnti-Inflammatory AgentsAntioxidantsCytokinesDoxorubicinHif1a protein, ratHypoxia-Inducible Factor 1, alpha SubunitInflammation MediatorsMelatoninNitric OxideAdrenomedullinAntioxidantsCardiotoxicityDoxorubicinECGMelatonin

Identifiers

PMID33389601
OpenAlexW3119310840

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.